Table of Contents Table of Contents
Previous Page  320 / 398 Next Page
Information
Show Menu
Previous Page 320 / 398 Next Page
Page Background

315

6 months. There was a palpable tight fibrous band over the left buc-

cal mucosa. Computed tomography scan reported of an ill-defined

soft tissue mass in the left oropharynx region involving the left

medial and lateral pterygoid muscle, infratemporal fossa, tempo-

ralis muscle, maxilla, ramus of mandible and extends into the left

parapharyngeal space. Histopathology examination reported the

lesion as plasmacytoma and her bone marrow trephine result was

negative for myeloma. She was diagnosed with extramedullary

plasmacytoma of the left oropharynx. She completed the radio-

therapy treatment, and currently she is free of disease for two

years.

Conclusion:

Extramedullary plasmacytoma often occur in the

posterior mandible region and frequently occurs within themucosa

of the oral cavity and pharynx. It has a favourable prognosis of

70% 10-year survival (Weber DM, 2005).

http://dx.doi.org/10.1016/j.ijom.2017.02.1060

Expression of fibroblast growth factor receptor type 2 in

primary and recurrent ameloblastoma are correlated with

ameloblastoma clinic characteristics

Y. Tang

∗

, T. Ji

Department of Oral Maxillofacial and Head Neck Oncology,

Ninth People’s Hospital, Shanghai JiaoTong University School

of Medicine, China

Background:

Fibroblast growth factor receptor type 2 (FGFR2),

a receptor tyrosine kinase, is involved in a number of cell

signalling pathways that contribute to cell growth and differentia-

tion. Whether it presence in primary ameloblastoma and recurrent

ameloblastoma has not been previously investigated.

Objectives:

This study was undertaken to detect the immunohis-

tochemical expression of the FGFR2 in primary ameloblastoma

and recurrent ameloblastoma, and to determine if it was involved

in the development of ameloblastoma, especially in the invasion

and recurrence of ameloblastoma.

Methods:

In this study, 96 formalin-fixed, paraffin-embedded tis-

sue blocks of ameloblastoma specimens which come from patients

with two surgery and patients with only one surgery were com-

pared at protein expression level using immunohistochemistry for

FGFR2 staining.

Finding:

The results indicated that, FGFR2 immunostaining was

evident in all groups of the specimens, the staining in recurrence

ameloblastoma was stronger than in primary ameloblastoma.

Statistical analysis showed that FGFR2 expression levels were

significantly higher in recurrence ameloblastoma than in primary

ameloblastoma, and the patient with tumour size over 3 cm had a

higher rate of recurrence.

Conclusion:

Our study suggests that the high expression rate of

FGFR2 plays an important role in the invasion and recurrence of

ameloblastoma.

http://dx.doi.org/10.1016/j.ijom.2017.02.1061

Clinical feature of Sjögren’s syndrome in our hospital

comparison of the Japanese criteria with the internationally

approved criteria edited by American College of

Rheumatology

S. Tsuchida

∗

, A. Nagayama, D. Uchida, H. Kawamata

Department of Oral and Maxillofacial Surgery, Dokkyo Medical

University School of Medicine, Tochigi, Japan

Background:

The revised criteria for the diagnosis of Sjögren’s

syndrome (SS) issued by the Japanese Ministry of Health study

group (JPN) is usually used in daily clinical practice and clin-

ical study for SS in Japan. On the other hands, the American

College of Rheumatology (ACR) classification criteria for SS are

internationally used.

Objectives:

We reported the clinical feature of Sjögren’s syn-

drome in our hospital, and examined the characteristics of JPN

criteria when compared with ACR criteria.

Methods:

248 patients diagnosed with SS by the JPN criteria in

our Hospital from 2007 to 2015 were retrospectively re-diagnosed

by ACR criteria, and were examined the difference and the char-

acteristics of these diagnosis criteria.

Findings:

70 (28%) patients diagnosed by JPN criteria did not

meet ACR criteria. Nine patients who met JPN histopathologi-

cal criteria did not fulfil ACR criteria. Conversely, two patients

who met ACR histopathological criteria did not fulfil JPN crite-

ria. Five patients who met ACR serological criteria did not fulfil

JPN criteria.

Discussion and Conclusion:

Relative sensitivity of JPN crite-

ria might be higher than that of ACR criteria, conversely relative

specificity of ACR criteria might be higher than that of JPN crite-

ria. Because SS was developed based on autoimmune disorder,

when the disease was diagnosed by only clinical signs and symp-

tom, such as dry mouth and dry eyes without any serological

and histopathological abnormality, the diagnosis would be over-

diagnosis. We should understand the characteristics of several

diagnosis criteria for SS, and utilise these criteria to reach true

SS.

http://dx.doi.org/10.1016/j.ijom.2017.02.1062

A case of spontaneous regression of plasmablastic lymphoma

in the upper gingiva

M. Yao

∗

, N. Yoshioka, K. Hasegawa, T. Shimo, A. Sasaki

Okayama University Graduate School of Medicine, Dentistry

and Pharmaceutical Sciences, Japan

Background:

Plasmablastic lymphoma (PBL) is a rare, aggres-

sive neoplasm that most commonly occurs in immunodeficient

patients. The most common site of PBL is the oral cavity and the

prognosis is poor. Spontaneous regression of malignant lymphoma

is extremely unusual. Here, we report a spontaneous regression of

PBL in the upper gingiva without any treatment.

Case Report:

An 80-year-old male was referred with a swelling

at the right upper gingiva. He had been extracted the second

molar at the same side before two months at a private dental

clinic. Computed tomography (CT) scan demonstrated a mass

involving alveolar bone at the right upper molar region. Positron

emission tomography-CT showed hypermetabolic lesion on the

right side of the maxilla with increased fluorodeoxyglucose uptake